Thanks posters above for clarifying. Sounds like it could be more of a distortionary threat then.
It would be a shame for the patient if this initiative redirected investment toward less effective but higher NPAT biotechs with new patents in similar spaces. Gov might need to think it through a bit harder.
General Comments / Chat, page-2855
-
-
- There are more pages in this discussion • 8,434 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.52 |
Change
-0.030(1.94%) |
Mkt cap ! $260.6M |
Open | High | Low | Value | Volume |
$1.57 | $1.57 | $1.50 | $33.68K | 22.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 2472 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190 | 1.515 |
1 | 649 | 1.510 |
3 | 6962 | 1.505 |
6 | 39227 | 1.500 |
1 | 950 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 2472 | 3 |
1.550 | 303 | 1 |
1.565 | 607 | 1 |
1.580 | 6715 | 2 |
1.595 | 12136 | 1 |
Last trade - 12.21pm 19/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |